Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Pagel

Showing results (11-20 of 187) with videos related to

Pageof 19
Sort By:
Blood|September 27, 2019
Duvelisib for CLL/SLL and follicular non-Hodgkin lymphomaKrish Patel, Alexey V Danilov, John M Pagel
Cancer Biotherapy & Radiopharmaceuticals|April 29, 2010
Pretargeted radioimmunotherapy for hematologic and other malignanciesRoland B Walter, Oliver W Press, John M Pagel
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Refining the management of relapsed or refractory follicular lymphoma: case scenariosJohn M Pagel, John M Burke, Lori A Leslie
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Chemoimmunotherapy Versus Targeted Treatment in Chronic Lymphocytic Leukemia: When, How Long, How Much, and in Which Combination?Jennifer R Brown, Michael J Hallek, John M Pagel
Clinical Advances in Hematology & Oncology : H&O|May 12, 2016
Discussion: Managing Risk When Using IdelalisibSteven E Coutre, Jan A Burger, John M Pagel
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Refining the management of relapsed or refractory follicular lymphomaJohn M Pagel, John M Burke, Lori A Leslie
Blood|December 26, 2003
Fenretinide enhances rituximab-induced cytotoxicity against B-cell lymphoma xenografts through a caspase-dependent mechanismAjay K Gopal, John M Pagel, Nathan Hedin, et al.
Current Opinion in Oncology|December 19, 2009
Recent advances in novel radioimmunotherapeutic approaches for allogeneic hematopoietic cell transplantationJaideep Shenoi, Ajay K Gopal, Oliver W Press, et al.
Hemasphere|November 15, 2019
Chemo-immunotherapy for Older Patients with Chronic Lymphocytic Leukemia - Passé Yet?Alexey V Danilov, John M Pagel, Jennifer R Brown, et al.
American Journal of Hematology|August 19, 2007
Therapeutic use of Rituximab for sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease)John M Pagel, Jack Lionberger, Ajay K Gopal, et al.
Pageof 19

Showing results (11-20 of 187) with videos related to

Sort By:
Pageof 19
Blood|September 27, 2019
Duvelisib for CLL/SLL and follicular non-Hodgkin lymphomaKrish Patel, Alexey V Danilov, John M Pagel
Cancer Biotherapy & Radiopharmaceuticals|April 29, 2010
Pretargeted radioimmunotherapy for hematologic and other malignanciesRoland B Walter, Oliver W Press, John M Pagel
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Refining the management of relapsed or refractory follicular lymphoma: case scenariosJohn M Pagel, John M Burke, Lori A Leslie
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Chemoimmunotherapy Versus Targeted Treatment in Chronic Lymphocytic Leukemia: When, How Long, How Much, and in Which Combination?Jennifer R Brown, Michael J Hallek, John M Pagel
Clinical Advances in Hematology & Oncology : H&O|May 12, 2016
Discussion: Managing Risk When Using IdelalisibSteven E Coutre, Jan A Burger, John M Pagel
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Refining the management of relapsed or refractory follicular lymphomaJohn M Pagel, John M Burke, Lori A Leslie
Blood|December 26, 2003
Fenretinide enhances rituximab-induced cytotoxicity against B-cell lymphoma xenografts through a caspase-dependent mechanismAjay K Gopal, John M Pagel, Nathan Hedin, et al.
Current Opinion in Oncology|December 19, 2009
Recent advances in novel radioimmunotherapeutic approaches for allogeneic hematopoietic cell transplantationJaideep Shenoi, Ajay K Gopal, Oliver W Press, et al.
Hemasphere|November 15, 2019
Chemo-immunotherapy for Older Patients with Chronic Lymphocytic Leukemia - Passé Yet?Alexey V Danilov, John M Pagel, Jennifer R Brown, et al.
American Journal of Hematology|August 19, 2007
Therapeutic use of Rituximab for sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease)John M Pagel, Jack Lionberger, Ajay K Gopal, et al.
Pageof 19